Archive: 02/03/2020
Gilead Sciences buying Forty Seven for $4.9 billion
Gilead Sciences is buying the cancer treatment company Forty Seven in a deal valued at approximately $4.9 billion.
Mar 2, 2020
Gilead Sciences is buying the cancer treatment company Forty Seven in a deal valued at approximately $4.9 billion.
Mar 2, 2020